Skip to main content

Table 1 PRM verified proteins in targeted proteomics analysis

From: Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification

Protein Accession

Gene name

SCC/H Ratio

SCC/H

p value

AC/H

Ratio

AC/H

p value

AC/SCC Ratio

AC/SCC

p value

P53621

COPA

2.07

4.00E−03

2.80

2.53E−04

1.35

2.95E−02

Q7Z3K3

POGZ

4.74

1.46E−04

6.43

4.98E−05

1.36

5.30E−02

Q8N2K0

ABHD12

2.86

2.12E−06

3.93

6.60E−03

1.37

1.11E−01

P04275

VWF

0.72

1.30E−01

0.75

2.07E−01

1.04

7.68E−01

Q6YHK3

CD109

1.08

6.71E−01

0.47

1.05E−03

0.44

3.49E−05

P52209

PGD

5.00

1.83E−03

3.00

1.12E−02

0.60

2.74E−02

P27482

CALML3

6.85

4.03E−03

0.93

9.36E−01

0.14

5.31E−05

P02671

FGA

0.35

1.99E−02

0.54

1.06E−01

1.53

2.61E−02

P02679

FGG

0.42

1.23E−02

0.61

8.61E−02

1.45

1.83E−02

P00568

AK1

0.90

5.27E−01

1.23

3.65E−01

1.37

5.33E−02

Q9UIJ7

AK3

0.96

7.95E−01

0.95

8.07E−01

0.99

9.55E−01

P43034

PAFAH1B1

1.31

1.26E−01

1.27

1.12E−01

0.97

7.92E−01

Q14624

ITIH4

0.48

7.14E−05

0.56

1.23E−03

1.16

2.92E−01

P01860

IGHG3

0.46

2.71E−05

0.44

1.32E−04

0.95

7.86E−01

Q9H223

EHD4

1.22

2.67E−01

1.33

1.35E−01

1.09

5.04E−01

P42765

ACAA2

0.97

8.73E−01

1.76

1.26E−01

1.81

1.80E−02

P02649

APOE

0.28

5.01E−06

0.46

6.79E−03

1.64

6.50E−02

Q9BSJ8

ESYT1

1.63

4.62E−04

1.62

7.65E−03

0.99

9.46E−01

O60716

CTNND1

5.21

5.00E−04

3.34

3.27E−04

0.64

1.79E−02